Status:
COMPLETED
Oral Steroids Before Pulmonary Vein Isolation to Improve Outcomes
Lead Sponsor:
Dhanunjaya Lakkireddy, MD, FACC
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The primary purpose of this study is to assess the efficacy of oral prednisone in improving the outcomes of pulmonary vein isolation with radiofrequency ablation.
Detailed Description
The purpose of this study is: 1. To assess the efficacy of oral prednisone in improving the outcomes of pulmonary vein isolation with radiofrequency ablation. 2. To measure the inflammatory cytokine ...
Eligibility Criteria
Inclusion
- Able to provide written informed consent;
- Scheduled for radiofrequency ablation procedure for treatment of atrial fibrillation
Exclusion
- History of heart failure (right or left or biventricular) or cardiomyopathy.
- Immunosuppressive disorders and systemic fungal infection
- Concurrent use of corticosteroids in one week prior recruitment.
- Allergy or prednisone or its components.
- Other medical conditions were use of corticosteroids is not recommended or contraindicated.
- Patients with chronic and permanent atrial fibrillation.
- Patients with established diagnosis of rheumatological and immunological disorders.
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01206452
Start Date
September 1 2010
End Date
December 1 2013
Last Update
May 17 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Of Kansas Medical Center
Kansas City, Kansas, United States, 66160